ncRNA name
LINC01503
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
GATA1
Downstream target
miR-766-5p/PD-L1
Cancer name
Ovarian Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Carboplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
GATA1-induced LINC01503 expedited CBP resistance in OCa cells via the miR-766-5p/PD-L1 axis
Tissue resource
normal human ovarian epithelial cell lines IOSE-80
human ovarian cancer cell lines SKOV-3
human ovarian cancer cell lines OVCAR-10
human ovarian cancer cell lines CAOV-3
human ovarian cancer cell lines OVCAR-3
Experiment
None
Institute
BeNa Culture Collection
Country
China
Continent
Asia